Aytu Bioscience (NASDAQ:AYTU) will be announcing its earnings results after the market closes on Thursday, November 14th. Analysts expect the company to announce earnings of ($0.30) per share for the quarter.

Aytu Bioscience (NASDAQ:AYTU) last announced its earnings results on Thursday, September 26th. The company reported ($0.32) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.33) by $0.01. Aytu Bioscience had a negative net margin of 370.62% and a negative return on equity of 204.18%. On average, analysts expect Aytu Bioscience to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Shares of Aytu Bioscience stock opened at $1.01 on Tuesday. Aytu Bioscience has a 1 year low of $0.68 and a 1 year high of $2.61. The firm has a market cap of $21.77 million, a PE ratio of -0.29 and a beta of 4.63. The company has a 50 day simple moving average of $1.14 and a two-hundred day simple moving average of $1.56.

Several equities research analysts have issued reports on AYTU shares. Zacks Investment Research lowered shares of Aytu Bioscience from a buy rating to a hold rating in a research report on Thursday, October 3rd. LADENBURG THALM/SH SH lifted their target price on shares of Aytu Bioscience from $4.00 to $4.75 in a research report on Wednesday, September 18th. ValuEngine lowered shares of Aytu Bioscience from a buy rating to a hold rating in a research report on Monday. Finally, Northland Securities set a $10.00 target price on shares of Aytu Bioscience and gave the company a buy rating in a research report on Friday, September 27th.

Aytu Bioscience Company Profile

Aytu BioScience, Inc, a specialty healthcare company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), insomnia, and male infertility in the United States and internationally. The company markets Natesto, a nasal gel for the treatment of hypogonadism (low testosterone) in men; and ZolpiMist, an oral spray for the treatment of insomnia.

Featured Story: Conference Calls and Individual Investors

Follow this link:
Aytu Bioscience (AYTU) Scheduled to Post Quarterly Earnings on Thursday - Polson News

Comments are closed.